Investigating the Biocompatibility of Biodegradable Subcutaneous Implant

Program Description: To investigate the biocompatibility, the drug release profile and length of prophylactic efficacy of a biodegradable subcutaneous implant containing antiretroviral drug(s), developed by RTI.
Funding Partners:
  • RTI International
Program Partners:
  • CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Program Location:
  • United States of America
HIV/AIDS
Infectious Disease
HIV